[1]李海霞,冀 湧,王荣华.缺氧缺血性脑病新生儿血清NF-L、AQP9、FGL2水平表达与NABA评分的相关性研究[J].现代检验医学杂志,2026,41(02):141-145.[doi:10.3969/j.issn.1671-7414.2026.02.024]
　LI Haixia,JI Yong,WANG Ronghua.Correlation Study Between Serum NF-L, AQP9 and FGL2 Levels and NABA Scores in Neonatal Hypoxic-Ischemic Encephalopathy[J].Journal of Modern Laboratory Medicine,2026,41(02):141-145.[doi:10.3969/j.issn.1671-7414.2026.02.024]
点击复制

缺氧缺血性脑病新生儿血清NF-L、AQP9、FGL2水平表达与NABA评分的相关性研究()

《现代检验医学杂志》[ISSN:/CN:]

卷:
第41卷
期数:
2026年02期
页码:
141-145
栏目:
论著
出版日期:
2026-03-15

文章信息/Info

Title:
Correlation Study Between Serum NF-L, AQP9 and FGL2 Levels and NABA Scores in Neonatal Hypoxic-Ischemic Encephalopathy
文章编号:
1671-7414（2026）02-141-05
作者:
李海霞，冀 湧，王荣华
山西省儿童医院新生儿重症监护病房，太原 030000
Author(s):
LI Haixia，JI Yong，WANG Ronghua
NICU of Shanxi Children’s Hospital, Taiyuan 030000, China
关键词:
新生儿缺氧缺血性脑病; 神经纤维轻链; 水通道蛋白9; 纤维蛋白原样蛋白2; 新生儿行为神经评估
分类号:
R742；R392.11
DOI:
10.3969/j.issn.1671-7414.2026.02.024
文献标志码:
A
摘要:
目的?通过研究缺氧缺血性脑病(HIE)新生儿血清神经纤维轻链(NF-L)、水通道蛋白9(AQP9)、纤维蛋白原样蛋白2(FGL2)水平的变化,分析三者与新生儿行为神经评估(NABA)评分的相关性。方法选取2022年1月~2024年7月山西省儿童医院收治的203例HIE患儿为研究组,根据病情程度分为轻度组(n=63)、中度组(n=81)和重度组(n=59),另选同期的健康新生儿203例为对照组,酶联免疫吸附试验(ELISA)检测血清NF-L、AQP9、FGL2水平,收集分析一般临床资料。受试者操作特征(ROC)曲线分析NF-L、AQP9、FGL2及NABA评分对新生儿重度HIE的诊断价值;Pearson法分析血清NF-L、AQP9、FGL2与NABA评分的相关性。结果与对照组相比,研究组血清NF-L(14.78±1.67ng/mlvs10.65±1.21ng/ml)、AQP9(61.82±6.29pg/mlvs42.62±4.31pg/ml)、FGL2(189.69±20.26ng/mlvs132.51±14.84ng/ml)水平显著升高,差异具有统计学意义(t=28.533、35.877、32.440,均P<0.05);中度组、重度组血清NF-L(14.68±1.67ng/ml、18.62±2.03ng/ml),AQP9(63.51±6.44pg/ml、69.63±7.03pg/ml),FGL2(195.68±20.84ng/ml、210.65±22.36ng/ml)水平显著高于轻度组(11.32±1.33ng/ml、52.32±5.41pg/ml、162.35±17.55ng/ml),NABA(34.89±3.51分、29.88±3.43分)评分显著低于轻度组(36.54±1.52分),差异具有统计学意义(t中度组=4.616~16.729,t重度组=17.276~33.701,均P<0.05);NF-L、AQP9、FGL2与NABA评分均呈负相关(r=-0.432、-0.421、-0.402,均P<0.05);NF-L、AQP9、FGL2、NABA联合诊断患儿重度病情的曲线下面积(AUC)显著高于各项单独诊断,差异具有统计学意义(Z=2.066~3.307,均P<0.05)。结论HIE患儿血清NF-L、AQP9、FGL2水平显著升高,与NABA评分相关,可能成为评估HIE患儿病情的标志物。
Abstract:
Objective To investigate the changes in serum levels of neurofilament light chain (NF-L), aquaporin 9 (AQP9), and fi-brinogen-like protein 2 (FGL2) in neonatal hypoxic-ischemic encephalopathy (HIE), and to analyze the correlation between the three markers and the neonatal behavioral neurological assessment (NABA) scores in affected infants. Methods From January 2022 to July 2024, 203 infants with HIE admitted to Shanxi Children's Hospital were enrolled as the patient group. According to disease se-verity, they were assigned into mild group (63 cases), moderate group (81 cases) and severe group (59 cases). An additional 203 healthy neonates from the same period were selected as the control group. Serum NF-L, AQP9 and FGL2 levels were measured by ELISA. General clinical data were collected and analyzed. Receiver operating characteristic (ROC) curves were plotted to analyze the diagnostic value of NF-L, AQP9, FGL2 and NABA scores for severe HIE in neonates. Pearson correlation analysis method was used to assessed the correlation between serum NF-L, AQP9, FGL2 and NABA scores. Results Compared with the control group, the patient group exhibited significantly higher serum levels of serum NF-L (14.78±1.67 ng/ml vs 10.65±1.21 ng/ml), AQP9(61.82±6.29 pg/ml vs 42.62±4.31 pg/ml) and FGL2 (189.69±20.26 ng/ml vs 132.51±14.84 ng/ml) (t=28.533, 35.877, 32.440, all P<0.05). Serum levels of NF-L (14.68±1.67 ng/ml, 18.62±2.03 ng/ml), AQP9(63.51±6.44 pg/ml, 69.63±7.03 pg/ml) and FGL2 (195.68±20.84 ng/ml, 210.65±22.36 ng/ml) were significantly higher in the severe and moderate groups than those in the mild groups(11.32±1.33 ng/ml, 52.32±5.41 pg/ml, 162.35±17.55 ng/ml), while the NABA score (34.89±3.51, 29.88±3.43) was significantly lower than that in the mild groups (36.54±1.52)(tmoderate group=4.616~16.729, tsevere group=17.276~33.701, all P<0.05). NF-L, AQP9 and FGL2 levels were all negatively correlated with NABA scores (r=-0.432, -0.421, -0.402, all P<0.05). The AUC for combined diagnosis of severe disease using NF-L, AQP9, FGL2 and NABA was significantly higher than that for individual markers (Z=2.066~3.307, all P<0.05). Conclusions Serum levels of NF-L, AQP9, and FGL2 in neonates with HIE are greatly ele-vated and correlated with NABA score, potentially serving as biomarkers for assessing HIE severity.

参考文献/References:

[1] WU Y W, COMSTOCK B A, GONZALEZ F F, et al. Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns[J]. the New England Journal of Medicine, 2022, 387(2): 148-159.
[2] VICTOR S, ROCHA-FERREIRA E, RAHIM A, et al. New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy[J]. European Journal of Pediatrics, 2022, 181(3): 875-887.
[3] 张丽蓉,林艾,杨丽.缺氧缺血性脑病新生儿血清miR-139-5p, HDAC4和GFAP表达水平及其临床价值研究[J].现代检验医学杂志,2024,39(1):55-60. ZHANG L R, LIN A, YANG L. Study on the expression levels of serum miR-139-5p, HDAC4 and GFAP in neonates with hypoxic-ischemic encephalopathy and their clinical value[J]. Journal of Modern Laboratory Medicine, 2024, 39(1): 55-60.
[4] ZHOU J J, LI S S, GU L, et al. General movement assessment is correlated with neonatal behavior neurological assessment/cerebral magnetic resonance imaging in preterm infants[J]. Medicine (Baltimore), 2021, 100(37): e27262.
[5] ZHAO Y H, ARCENEAUX L, CULICCHIA F, et al. Neurofilament light (NF-L) chain protein from a highly polymerized structural component of the neuronal cytoskeleton to a neurodegenerative disease biomarker in the periphery[J]. HSOA Journal of Alzheimer’s &Neurodegenerative Diseases, 2021, 7(2): 56.
[6] GAFSON A R, BARTH?LEMY N R, BOMONT P, et al. Neurofilaments: neurobiological foundations for biomarker applications[J]. Brain: a Journal of Neurology, 2020, 143(7): 1975-1998.
[7] GAO C, SHEN J B, YAO L Q, et al. Low expression of AQP9 and its value in hepatocellular carcinoma[J]. Translational Cancer Research, 2021, 10(4): 1826-1841.
[8] 谭郎敏,刘翠芳,范蕊,等.血清AQP9、HIF-1α水平与急性缺血性脑卒中出血性转化的相关性分析[J]. 保健医学研究与实践, 2023, 20(7): 27-30. TAN L M, LIU C F, FAN R, et al. Correlation between serum AQP9, HIF-1α levels and hemorrhagic transformation in acute ischemic stroke[J]. Health Medicine Research and Practice, 2023, 20(7): 27-30.
[9] MA X Y, ZHU H T, CHENG L D, et al. Targeting FGL2 in glioma immunosuppression and malignant progression[J]. Frontiers in Oncology, 2022, 12:1004700.
[10] 李伟,李宗奇,宁波,等.血清NRG1、FGL2、FGF9与急性缺血性脑卒中后癫痫的关系及其预测价值研究[J].现代生物医学进展, 2024, 24(13):2587-2591, 2541. LI W, LI Z Q, NING B, et al. Study on the relationship between serum NRG1, FGL2, FGF9 and epilepsy after acute ischemic stroke and its predictive value[J]. Progress in Modern Biomedicine, 2024, 24(13): 2587-2591, 2541.
[11] 中华医学会儿科学分会新生儿学组.新生儿缺氧缺血性脑病诊断标准[J].中国当代儿科杂志,2005,7(2):97-98. The Subspecialty Group of Neonatology,Pediatric Society,Chinese Medical Association. Diagnostic criteria for neonatal hypoxic-ischemic encephalopathy[J]. Chinese Journal of Contemporary Pediatrics, 2005, 7(2): 97-98.
[12] RANJAN A K, GULATI A. Advances in therapies to treat neonatal hypoxic-ischemic encephalopathy[J]. Journal of Clinical Medicine, 2023, 12(20): 6653.
[13] EDOIGIAWERIE S, HENRY J, ISSA N, et al. A systematic review of EEG and MRI features for predicting long-term neurological outcomes in cooled neonates with hypoxic-ischemic encephalopathy(HIE) [J]. Cureus, 2024, 16(10): e71431.
[14] S?NCHEZ-RODR?GUEZ E C, L?PEZ V J. Hypoxic ischemic encephalopathy(HIE)[J]. Frontiers in Neurology, 2024, 15: 1389703.
[15] DUMBUYA J S, CHEN L, WU J Y, et al. The role of G-CSF neuroprotective effects in neonatal hypoxic-ischemic encephalopathy (HIE): current status[J]. Journal of Neuroinflammation, 2021, 18(1): 55.
[16] ZHOU K Q, MCDOUALL A, DRURY P P, et al. Treating seizures after hypoxic-ischemic encephalopathy-current controversies and future directions[J]. International Journal of Molecular Sciences, 2021, 22(13): 7121.
[17] LADANG A, KOVACS S, LENGEL? L, et al.Neurofilament-light chains(NF-L), a biomarker of neuronal damage,is increased in patients with severe sarcopenia:results of the SarcoPhAge study[J]. Aging Clinical and Experimental Research, 2023, 35(10):2029-2037.
[18] ZHANG X T, WANG H X, LI L, et al. Neurofilament light chain: a candidate biomarker of perioperative stroke[J]. Frontiers in Aging Neuroscience, 2022, 14:921809.
[19] THEBAULT S, BOOTH R A, FREEDMAN M S. Blood neurofilament light chain: the neurologist’s troponin?[J]. Biomedicines, 2020, 8(11): 523.
[20] 张晓丽,刘彦超,夏磊,等.NBNA评分联合磁共振弥散张量成像在早产儿脑白质发育评价中的作用及相关性分析[J].中国当代儿科杂志,2021,23(9):916-921. ZHANG X L, LIU Y C, XIA L, et al. Role of neonatal behavioral neurological assessment combined with magnetic resonance diffusion tensor imaging in evaluating white matter development in preterm infants[J]. Chinese Journal of Contemporary Pediatrics, 2021, 23(9): 916-921.
[21] SHI Y D, YASUI M, HARA-CHIKUMA M. AQP9 transports lactate in tumor-associated macrophages to stimulate an M2-like polarization that promotes colon cancer progression[J]. Biochemistry and Biophysics Reports, 2022, 31: 101317.
[22] CZY?EWSKI W, LITAK J, SOBSTYL J, et al. Aquaporins: gatekeepers of fluid dynamics in traumatic brain injury[J]. International Journal of Molecular Sciences, 2024, 25(12): 6553.
[23] OPDAL S H, FERRANTE L, ROGNUM T O, et al. Aquaporin-1 and aquaporin-9 gene variations in sudden infant death syndrome[J]. International Journal of Legal Medicine, 2021, 135(3): 719-725.
[24] MU C Q, WANG Y Z, HAN C, et al. Crosstalk between oxidative stress and neutrophil response in early ischemic stroke: a comprehensive transcriptome analysis[J]. Frontiers in Immunology, 2023, 14:1134956.
[25] CHEN J M, WU L, LI Y S. FGL1 and FGL2: emerging regulators of liver health and disease[J]. Biomarker Research, 2024, 12(1): 53.
[26] ZHAN D, ZHANG C, LONG W J, et al. Intrauterine inflammation induced white matter injury protection by fibrinogen-like protein 2 deficiency in perinatal mice[J]. Pediatric Research, 2021, 89(7): 1706-1714.
[27] HUANG L J, ZHAN D, XING Y, et al. FGL2 deficiency alleviates maternal inflammation-induced blood-brain barrier damage by blocking PI3K/NF-κB mediated endothelial oxidative stress[J]. Frontiers in Immunology, 2023, 14: 1157027.
[28] YAO X Y, SONG Y Y, WANG Z, et al. Proteinase-activated receptor-1 antagonist attenuates brain injury via regulation of FGL2 and TLR4 after intracerebral hemorrhage in mice[J]. Neuroscience, 2022, 490: 193-205.

备注/Memo

备注/Memo:
基金项目：山西省卫生健康委员会科研课题项目（2022A117）。
作者简介：李海霞（1989-），女，硕士，主治医师，研究方向：儿内科相关疾病基础与临床，E-mail：hx4861@sina.com。
通讯作者：冀湧（1969-），女，本科，主任医师，研究方向：儿内科相关疾病基础与临床。
更新日期/Last Update: 2026-03-15